3G 5mg + Solvent 2ml
3G – an innovative peptide in scientific research, also known as retatrutide, is a synthetic peptide developed as a triple agonist. This means that laboratory and clinical studies examine its simultaneous effects on three different receptors: GLP-1, GIP, Glucagon receptor.
Description
3G – an innovative peptide in scientific research
3G also known as retatrutide, is a synthetic peptide developed as a triple agonist. This means that laboratory and clinical studies examine its simultaneous effects on three different receptors:
- GLP-1 (glucagon-like peptide-1) – related to the regulation of glucose levels and the feeling of satiety,
- GIP (glucose-dependent insulinotropic peptide) – its role in insulin sensitivity is being studied,
- Glucagon receptor – whose activation is analyzed, among others, in the context of metabolic processes.
This unique combination makes 3G currently one of the most interesting research objects on the mechanisms of metabolic regulation.
Scientific interest
In recent years, retatrutide has become the subject of extensive clinical trials conducted by international research centers. Scientific publications indicate its research potential in the context of glucose metabolism and the body's energy management.
Status
Peptide is not approved as a drug, dietary supplement, or food. May only be used for scientific and educational purposes.















